2025-07-13 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA), based on the data you provided. The report is structured as requested, with numerical summaries followed by brief analyses.

**Report: Natera Inc. (NTRA) Analysis**

**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing, primarily in reproductive health, oncology, and organ health.

**1. Performance vs. S&P 500 (VOO)**

*   **NTRA Cumulative Return:** 126.35%
*   **VOO (S&P 500) Cumulative Return:** 95.76%
*   **Spread:** 31.1%
*   **Spread Range (Max: 631.9, Min: -39.3):**
*   **Relative Spread:** 10.5

**Analysis:** NTRA has outperformed the S&P 500 (VOO) in terms of cumulative return. However, the relative spread of 10.5 indicates that the current outperformance is relatively low compared to the historical range of outperformance. This suggests the stock's current position is closer to its lower historical performance relative to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha   | Beta | Cap(B) |
|------------|--------|--------|---------|------|--------|
| 2015-2017  | -6.0%  | 62.4%  | -31.0%  | 0.0  | 1.2    |
| 2016-2018  | 29.0%  | 80.1%  | 11.0%   | 0.0  | 1.9    |
| 2017-2019  | 159.0% | 80.1%  | 130.0%  | 1.2  | 4.6    |
| 2018-2020  | 530.0% | 80.1%  | 510.0%  | 0.3  | 13.6   |
| 2019-2021  | 355.0% | 62.9%  | 307.0%  | 0.2  | 12.8   |
| 2020-2022  | -119.0% | 62.9%  | -121.0% | 0.2  | 5.5    |
| 2021-2023  | -482.0% | 69.9%  | -500.0% | 1.1  | 8.6    |
| 2022-2024  | -75.0%  | 70.6%  | -100.0% | 1.2  | 21.6   |
| 2023-2025  | 75.0%  | 72.8%  | 28.0%   | 0.8  | 21.9   |

**Analysis:**

*   **CAGR:**  Shows highly variable annual growth, with periods of substantial gains and significant losses. The recent 2023-2025 period shows a 75% gain, indicating a potential recovery.
*   **MDD (Maximum Drawdown):** Consistently high MDD values (62.4% to 80.1%) indicate substantial risk and volatility.
*   **Alpha:**  Alpha values fluctuate significantly, correlating with CAGR.  Periods with high positive alpha (e.g., 2018-2020) indicate significant outperformance relative to the market, while negative alpha values (e.g., 2021-2023) indicate underperformance.
*   **Beta:** Beta values have varied from 0.0 to 1.2, suggesting that the stock's volatility relative to the market is not constant.
*   **Cap(B):** Market cap has seen significant growth, especially in recent periods, reaching $21.9 billion by 2025. This indicates increasing investor confidence or business expansion.

**2. Recent Stock Price Movements**

*   **Current Price:** $160.43
*   **Previous Close:** $163.36
*   **Change:** -$1.79
*   **5-day Moving Average:** 160.54
*   **20-day Moving Average:** 165.35
*   **60-day Moving Average:** 158.84

**Analysis:** The stock price has decreased slightly recently. The 5-day moving average is below the 20-day moving average, which could indicate a short-term downward trend. The current price is above the 60-day moving average, suggesting that the stock is still in a mid-term uptrend. The negative change from the previous close supports the short-term downward trend.

**3. Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 34.44 (Approaching Oversold)
*   **PPO:** -0.66
*   **Hybrid Signal:** Cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33) (Cash Ratio: 70% on 2025-07-03)
*   **Recent (20-day) Relative Spread Change:** 0.0 (Neutral)
*   **Expected Return (%):** 163.3%

**Analysis:**

*   The **MRI** indicates a low-risk environment.
*   The **RSI** value suggests that the stock is approaching oversold territory, which could indicate a potential buying opportunity.
*   The **PPO** being negative suggests a bearish trend in the stock's momentum.
*   The **Hybrid Signal** suggests a cautious approach, recommending a high cash ratio.
*   The stable **Recent Relative Spread Change** suggests no significant shifts in the stock's recent performance relative to its benchmark.
*   The **Expected Return** is very high, indicating significant optimism for long-term investors.

**4. Recent News & Significant Events**

*   **[2025-07-11]** Natera Inc (NTRA) has recently made headlines due to major business developments, regulatory changes, or market events.
*   **[2025-07-13]** Analysts are discussing Natera Inc's (NTRA) recent performance and its outlook in the context of industry trends and global economic factors.
*   **[2025-07-12]** Natera Inc (NTRA)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-09]** Market experts highlight both risks and opportunities for Natera Inc (NTRA), advising investors to monitor recent news and company announcements.

**Analysis:** Recent news suggests significant events impacting NTRA, with discussions on performance, volatility, and both risks and opportunities. Investors should closely monitor further developments.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출      |
|------------|--------|-----------|
| 2025-05-09 | -0.5   | 0.50 B$   |
| 2024-11-12 | -0.26  | 0.44 B$   |
| 2024-08-09 | -0.3   | 0.41 B$   |
| 2024-05-10 | -0.56  | 0.37 B$   |
| 2025-05-09 | -0.56  | 0.37 B$   |

**Analysis:**

*   **EPS (Earnings Per Share):**  Consistently negative EPS values indicate that the company is not currently profitable.
*   **Revenue:** Revenue has generally increased over the quarters, suggesting business growth, but it did fall and was repeated in the most recent quarter.

**6. Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $0.50B    | 63.12%        |
| 2024-12-31   | $0.48B    | 62.94%        |
| 2024-09-30   | $0.44B    | 61.79%        |
| 2024-06-30   | $0.41B    | 58.83%        |
| 2024-03-31   | $0.37B    | 56.72%        |

**Analysis:** Revenue and profit margin show an increase, indicating business growth and better efficiency.

**Capital and Profitability**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-03-31   | $1.24B    | -5.40%   |
| 2024-12-31   | $1.20B    | -4.50%   |
| 2024-09-30   | $0.88B    | -3.60%   |
| 2024-06-30   | $0.84B    | -4.48%   |
| 2024-03-31   | $0.79B    | -8.51%   |

**Analysis:**

*   **Equity:** Equity has been increasing, which suggests the company's financial health is improving.
*   **ROE (Return on Equity):** Negative ROE values reflect the company's inability to generate profit from its equity.

**7. Overall Analysis**

Natera Inc. exhibits high growth potential coupled with significant risk. While the company has outperformed the S&P 500, its historical volatility and recent underperformance relative to its own standards are noteworthy. Increasing revenue and profit margins are positive signs, but consistent negative EPS and ROE are major concerns. The stock's technical indicators suggest a possible buying opportunity, but the hybrid signal suggests a cautious approach. Recent news events indicate that monitoring the company's announcements and industry trends is crucial.

**In Summary:** Natera Inc. is a high-risk, high-reward stock. Its future success depends on achieving profitability and managing its inherent volatility. Investors should carefully weigh the potential gains against the risks before investing.
